Oral Treatment with Live <i>Lactobacillus reuteri</i> Inhibits the Allergic Airway Response in Mice

Abstract

Oral treatment with live L. reuteri can attenuate major characteristics of an asthmatic response in a mouse model of allergic airway inflammation. These results suggest that oral treatment with specific live probiotic strains may have therapeutic potential in the treatment of allergic airway disease.